author-photo

Sandrine Kraemer

Boehringer Ingelheim

3

Papers

25

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

2018 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (13)
A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib

2017 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
1248PA PHASE IB OPEN LABEL CLINICAL TRIAL OF CONTINUOUS ONCE DAILY ORAL AFATINIB (A) PLUS SIROLIMUS (S) IN PATIENTS (PTS) WITH EGFR MUTATION POSITIVE (EGFR M+) NSCLC AND/OR DISEASE PROGRESSION FOLLOWING PRIOR ERLOTINIB (E) OR GEFITINIB (G)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)